Home » Dr. Reddy’s to Increase R&D Spending
Dr. Reddy’s to Increase R&D Spending
Pharmaceutical major Dr. Reddy’s Laboratories (DRL) aims to increase the R&D spending on its three major research programmes, including the reverse cholesterol transport (RCT) area, in a bid to come out with pathbreaking molecules in the next 7–10 years.
Business Standard
Upcoming Events
-
07May
-
14May
-
30May